An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal Surgery
Stopped early · Not applicable
Conditions studied: Ulcerative Colitis, Familial Polyposis
In brief
This will be a prospective, multi-center, randomized, single blind study to collect and evaluate post-market clinical data on the SprayShield Adhesion Barrier System as an adjuvant to good surgical technique for the reduction of postoperative adhesion formation following major open abdominal surgery.
Key facts
- Study ID
- NCT01002287
- Run by
- Integra LifeSciences Corporation
- People needed
- 11
- Starts
- 2009-10-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2014-11-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of ulcerative colitis or familial polyposis and require two-stage surgery for treatment of either of these disorders will be eligible
Where it is running
- Covidien — Bedford, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.